Role of amyloid β1-42 and neuroimaging biomarkers in Alzheimer's disease

被引：0
作者：
Lista, Simone [1 ]
Emanuele, Enzo [2 ]
机构：
[1] Univ Roma Tor Vergata, Ctr Pharmaceut Biotechnol, I-00133 Rome, Italy
[2] Living Res Sas, I-27038 Robbio, PV, Italy
来源：
BIOMARKERS IN MEDICINE | 2011年 / 5卷 / 04期
关键词：
Alzheimer's disease; amyloid beta 1-42; amyloid plaques; biomarker; cerebrospinal fluid; mild cognitive impairment; MRI; DIAGNOSIS;
D O I：
10.2217/BMM.11.50
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：411 / 413
页数：3
相关论文
共 20 条
  • [1] Optimization protocol for amyloid-β peptides detection in human cerebrospinal fluid using SELDI TOF MS
    Albertini, Valentina
    Bruno, Anna
    Paterlini, Anna
    Lista, Simone
    Benussi, Luisa
    Cereda, Cristina
    Binetti, Giuliano
    Ghidoni, Roberta
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2010, 4 (03) : 352 - 357
  • [2] Amyloid-related biomarkers for Alzheimer's disease
    Andreasen, Niels
    Zetterberg, Henrik
    [J]. CURRENT MEDICINAL CHEMISTRY, 2008, 15 (08) : 766 - 771
  • [3] CSF markers for incipient Alzheimer's disease
    Blennow, K
    Hampel, H
    [J]. LANCET NEUROLOGY, 2003, 2 (10) : 605 - 613
  • [4] Alzheimer's disease
    Scheltens, Philip
    De Strooper, Bart
    Kivipelto, Miia
    Holstege, Henne
    Chetelat, Gael
    Teunissen, Charlotte E.
    Cummings, Jeffrey
    van der Flier, Wiesje M.
    [J]. LANCET, 2021, 397 (10284) : 1577 - 1590
  • [5] Validation of Alzheimer's disease CSF and plasma biological markers: The multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI)
    Buerger, Katharina
    Frisoni, Giovanni
    Uspenskaya, Olga
    Ewers, Michael
    Zetterberg, Henrik
    Geroldi, Cristina
    Binetti, Giuliano
    Johannsen, Peter
    Rossini, Paolo Maria
    Wahlund, Lars-Olof
    Vellas, Bruno
    Blennow, Kaj
    Hampel, Harald
    [J]. EXPERIMENTAL GERONTOLOGY, 2009, 44 (09) : 579 - 585
  • [6] Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
    Fagan, AM
    Mintun, MA
    Mach, RH
    Lee, SY
    Dence, CS
    Shah, AR
    LaRossa, GN
    Spinner, ML
    Klunk, WE
    Mathis, CA
    DeKosky, ST
    Morris, JC
    Holtzman, DM
    [J]. ANNALS OF NEUROLOGY, 2006, 59 (03) : 512 - 519
  • [7] Diagnosis and biomarkers of predementia in Alzheimer's disease
    Forlenza, Orestes V.
    Diniz, Breno S.
    Gattaz, Wagner F.
    [J]. BMC MEDICINE, 2010, 8
  • [8] Core candidate neurochemical and imaging biomarkers of Alzheimer's disease
    Hampel, Harald
    Buerger, Katharina
    Teipel, Stefan J.
    Bokde, Arun L. W.
    Zetterberg, Henrik
    Blennow, Kaj
    [J]. ALZHEIMERS & DEMENTIA, 2008, 4 (01) : 38 - 48
  • [9] Biomarkers for Alzheimer's disease therapeutic trials
    Hampel, Harald
    Wilcock, Gordon
    Andrieu, Sandrine
    Aisen, Paul
    Blennow, Kaj
    Broich, K.
    Carrillo, Maria
    Fox, Nick C.
    Frisoni, Giovanni B.
    Isaac, Maria
    Lovestone, Simon
    Nordberg, Agneta
    Prvulovic, David
    Sampaio, Christina
    Scheltens, Philip
    Weiner, Michael
    Winblad, Bengt
    Coley, Nicola
    Vellas, Bruno
    [J]. PROGRESS IN NEUROBIOLOGY, 2011, 95 (04) : 579 - 593
  • [10] Biological markers of amyloid β-related mechanisms in Alzheimer's disease
    Hampel, Harald
    Shen, Yong
    Walsh, Dominic M.
    Aisen, Paul
    Shaw, Les M.
    Zetterberg, Henrik
    Trojanowski, John Q.
    Blennow, Kaj
    [J]. EXPERIMENTAL NEUROLOGY, 2010, 223 (02) : 334 - 346
12